Actively Recruiting
Efficacy of a 2'-Fucosylactose-based Food Supplement on the Prevention of Respiratory and Gastrointestinal Infections.
Led by University of Bari · Updated on 2025-07-09
100
Participants Needed
1
Research Sites
54 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Respiratory and gastrointestinal infections are frequent problems in children under 4 years of age, especially after the start of schooling. These conditions are facilitated by an incomplete maturation of the immune system and by the anatomical and functional structure of the respiratory and gastrointestinal tract still in development. Functional foods derived from the fermentation of cow's milk with probiotic strains have been proposed for the prevention of infectious diseases in children. Several products have been investigated, sometimes with conflicting results. Some scientific evidence has shown that the administration of Vitamin D, Zinc, Beta glucan, 2'-Fucosyllactose can stimulate the immune defenses and reduce the number and severity of infectious episodes. In particular, 2'-fucosyllactose is one of the oligosaccharides of breast milk. It has both a prebiotic and immunoregulatory action since it is able to prevent the adhesion of pathogens to epithelial surfaces and subsequent translocation. Healthy school-going children aged between 12 and 48 months, who attend school at least 5 days a week, will be evaluated.
CONDITIONS
Official Title
Efficacy of a 2'-Fucosylactose-based Food Supplement on the Prevention of Respiratory and Gastrointestinal Infections.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy school-going children aged 12 to 48 months who attend school at least 5 days a week
You will not qualify if you...
- Age less than 12 months or more than 48 months
- Presence of chronic diseases
- Congenital heart disease
- Tuberculosis
- Functional gastrointestinal disorders
- Gastrointestinal or urinary surgery of the respiratory tract
- Autoimmune diseases
- Immunodeficiencies
- Chronic inflammatory bowel diseases
- Celiac disease
- Cystic fibrosis
- Metabolic diseases
- Lactose intolerance
- Tumors
- Chronic lung diseases and malformations of the gastrointestinal tract
- Food allergies
- Eosinophilic esophagitis
- Other hypereosinophilic diseases of the gastrointestinal tract
- Diarrhea at enrollment
- Severe malnutrition (z score for weight/height less than 3SD)
- Taking antibiotics and/or pre/pro/symbiotics/immunostimulants within 2 weeks of starting the study
- Breastfeeding in progress
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pediatria Trambusti
Bari, Bari, Italy, 70100
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here